Answers are grounded in this paper and cite their sources.
Our data suggest that α5β1-mediated cross-talk between fibronectin and oxLDL regulates inflammation in early atherogenesis and that therapeutics that inhibit α5 integrins may reduce inflammation without adversely affecting plaque structure.
No takes yet. Share an insight, caveat, or question.
Yurdagul et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: